Advertisement
Screener

NEUROCRINE BIOSCIENCES INC (NBIX) Deferred State and Local Income Tax Expense (Benefit)

NEUROCRINE BIOSCIENCES INC Deferred State and Local Income Tax Expense (Benefit)

NEUROCRINE BIOSCIENCES INC (NBIX) reported Deferred State and Local Income Tax Expense (Benefit) of $1.90 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-11.

Financial Statements › Expense Statement › Income Tax

us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit · last filed 2026-02-11

  • NEUROCRINE BIOSCIENCES INC deferred state and local income tax expense (benefit) for fiscal 2025 was $1.90M.
  • NEUROCRINE BIOSCIENCES INC deferred state and local income tax expense (benefit) for fiscal 2024 was -$18.10M.
  • NEUROCRINE BIOSCIENCES INC deferred state and local income tax expense (benefit) for fiscal 2023 was -$15.50M.
  • NEUROCRINE BIOSCIENCES INC deferred state and local income tax expense (benefit) for fiscal 2022 was -$5.50M.
Period endDeferred State and Local Income Tax Expense (Benefit) 12 month
2025-12-31$1.90M
10-K · filed 2026-02-11
2024-12-31-$18.10M
10-K · filed 2026-02-11
2023-12-31-$15.50M
10-K · filed 2026-02-11
2022-12-31-$5.50M
10-K · filed 2025-02-10
2021-12-31-$400.00K
10-K · filed 2024-02-09
2020-12-31-$23.20M
10-K · filed 2023-02-09
2019-12-31$0.00
10-K · filed 2022-02-11
2018-12-31$0.00
10-K · filed 2021-02-05

Similar stocks

Stock NameCountryMarket CapPE Ratio
EXELIXIS, INC. (EXEL)United States$14.358B16.15
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
Immunovant, Inc. (IMVT)United States$7.028B-14.78